E
Mangoceuticals, Inc. MGRX
$0.71 -$0.60-45.57% NASDAQ
Recommendation
Prev Close
$1.31
Volume
9,876,055
Avg Vol (90D)
1,067,060
Market Cap
$18.22M
Dividend & Yield
--
52-Week Range
$0.98 - $6.15
P/E (TTM)
--
EPS (TTM)
-$3.36
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
12/19/2025 - GuruFocus
Mangoceuticals Announces Solana-Focused $100M Digital Asset Treasury, Sees 'Compelling, Non-Dilutive Returns'
12/19/2025 - Stocktwits News Feed
Mangoceuticals, Inc. Announces Closing of $2.5 Million Registered Direct and Private Placements
12/19/2025 - Globe Newswire
Mangoceuticals Announces New Financing Through Equity Offering
12/19/2025 - TipRanks Financial Blog
Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million ...
12/19/2025 - GuruFocus
Mangoceuticals (MGRX) Launches $100M Solana-Focused Treasury Strategy
12/19/2025 - GuruFocus
Mangoceuticals, Cube Group partner for up to $100M Solana-focused DAT strategy
12/19/2025 - TipRanks Financial Blog
Mangoceuticals, Cube Group partner for up to $100M Solana-focused DAT strategy
12/19/2025 - The Fly
Mangoceuticals, Inc. Announces Partnership with The Cube Group to Launch Up To $100 Million Solana-Focused Digital Asset Treasury (DAT) Strategy
12/19/2025 - Globe Newswire
Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at ...
12/18/2025 - GuruFocus
Mangoceuticals prices $2.5M registered direct offering with warrants
12/18/2025 - SeekingAlpha.com: All News
Mangoceuticals announces $2.5M registered direct, private placements
12/18/2025 - TipRanks Financial Blog
Mangoceuticals announces $2.5M registered direct, private placements
12/18/2025 - The Fly
Mangoceuticals, Inc. Announces $2.5 Million Registered Direct and Private Placements Priced at the Market Under Nasdaq Rules
12/18/2025 - Globe Newswire
Eugene Johnston Sells 5,000 Shares of Mangoceuticals Inc (MGRX)
12/12/2025 - GuruFocus
Insider Selling: Mangoceuticals (NASDAQ:MGRX) CFO Sells 10,000 Shares of Stock
12/10/2025 - MarketBeat
Insider Selling: Mangoceuticals (NASDAQ:MGRX) Director Sells 125,000 Shares of Stock
11/27/2025 - MarketBeat
Mangoceuticals (NASDAQ:MGRX) Director Sells $152,500.00 in Stock
11/26/2025 - Ticker Report
Are Direct-to-Consumer Channels Reinforcing Eli Lilly's (LLY) Competitive Edge in the Obesity Market?
11/18/2025 - Simply Wall St
Mangoceuticals (MGRX) Shares Plunge After Denying Partnership with Eli Lilly and Novo Nordisk
11/14/2025 - GuruFocus
Mangoceuticals plunges after denying Lilly, Novo partnerships
11/14/2025 - Seeking Alpha - Healthcare
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
11/14/2025 - GuruFocus
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
11/14/2025 - GuruFocus
Mangoceuticals Provides Clarification on Launch of Branded GLP-1 Weight-Management Programs
11/14/2025 - Globe Newswire
Eli Lilly (LLY) Clarifies No Ties with Mangoceuticals
11/13/2025 - GuruFocus
Income Statement
Total Revenue (TTM)
$466.80K
EBITDA (TTM)
-$16.49M
EBIT (TTM)
-$18.49M
Net Income (TTM)
-$19.82M
Balance Sheet
Total Assets (Q)
$16.53M
Total Debt (Q)
$112.20K
Total Liabilities (Q)
$804.30K
Book Value Per Share (Q)
$1.13
Cash Flow
Cash from Operations (TTM)
-$5.90M
Cash from Investing (TTM)
$0.00
Cash from Financing (TTM)
$6.31M
Net Change in Cash (TTM)
$407.30K
Filings
Filing Date
Friday, November 14, 2025
Period Date
Tuesday, September 30, 2025
Next Filing
Week of Mar 16 and 20 (est)
Price History
Loading...
Beta
-0.35
7-Day Total Return
-35.18%
30-Day Total Return
-61.25%
60-Day Total Return
-68.31%
90-Day Total Return
-58.06%
Year to Date Total Return
-71.37%
1-Year Total Return
-70.78%
2-Year Total Return
-83.16%
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Nov 13, 2025 - $0.98
52-week High
Feb 20, 2025 - $6.15
Valuation
Market Cap
$18.22M - Nano Cap
Enterprise Value
$17.85M
Price/Sales (TTM)
32.35
Price/Book (Q)
1.16
Dividends and Shares
Shares Outstanding
11.52
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.mangoceuticals.com
Phone Number
214 242 9619
Address
15110 N. Dallas Parkway
Dallas, TX 75248
Country
United States
Year Founded
2021
Business Description
Sector
Consumer Staples
Industry
Consumer Staples Distribution and Retail
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men’s wellness products and services through a telemedicine platform in the United States. The company offers... more
NASDAQ 12/19/2025 4:00PM Eastern Quotes delayed